Orphan drug designation for gene therapy treatment of rare genetic disease
Orchard Therapeutics Ltd. Receives Orphan Drug Designation for OTL-201, ex-vivo lentiviral gene therapy treatment for Mucopolysaccharidosis type IIIA
Read more
Orchard Therapeutics Ltd. Receives Orphan Drug Designation for OTL-201, ex-vivo lentiviral gene therapy treatment for Mucopolysaccharidosis type IIIA
Read more
Results from a national research awareness survey, supported by the NIHR Manchester Clinical Research Facility (CRF), have been recently completed by the UK CRF Network.
Read more
A wearable medical device that monitors kidney function and could reduce the time spent by transplant patients in hospital has won a prestigious innovation award.
Read more
Aimed at health and research professionals, particularly those aiming to become Chief Investigators
Read more
Around 200 staff attended events held at CMFT, The Christie and UHSM on and around 15 May to celebrate ICTD and learn more about the CRF’s five-year strategy and how to access its services.
Read more
Congratulations to Sasi Neelamekam and Anam Asif, Senior Trial Coordinators from CMFT who were successful at the 2017 Pharma Times Awards, bringing home the coveted Clinical Research Site of the Year
Read more
Alex blogs about spreading the word about research at the Saint Mary's Hospital recruitment day in May.
Read more
Award support researchers who are transforming great ideas into healthcare innovations that could have a significant impact on human health.
Read more